FGFR2: Fibroblast growth factor receptor 2
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development.
- Drugs that act on it: 12
- With a US drug page: 3
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Palifermin | Approved | Fibroblast growth factor receptor 2 agonist | Agonist | — |
| Pemigatinib | Approved | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| Regorafenib | Approved | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | Boxed warning |
| Aprutumab ixadotin | — | Fibroblast growth factor receptor 2 binding agent | Binding agent | — |
| Bemarituzumab | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| E-7090 | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| Fgfr inhibitor debio 1347 | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| HMPL-453 | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| Lucitanib | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| RG-1530 | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| TG100-801 | — | Fibroblast growth factor receptor 2 inhibitor | Inhibitor | — |
| Trafermin | — | Fibroblast growth factor receptor 2 agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Crouzon syndrome
- 0.86
- Pfeiffer syndrome
- 0.85
- Apert syndrome
- 0.83
- Beare-Stevenson cutis gyrata syndrome
- 0.82
- Jackson-Weiss syndrome
- 0.81
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis
- 0.81
- Cancer
- 0.80
- LADD syndrome
- 0.80
- Bent bone dysplasia syndrome 1
- 0.78
- LADD syndrome 1
- 0.78
- Acrocephalosyndactyly
- 0.76
- Gastric cancer
- 0.74
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- FGFR2
Drugs and mechanisms are from ChEMBL CHEMBL4142 (CC BY-SA 3.0). Gene name, function (UniProt P21802, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets